 Shaikh Atif
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 11 | 2021 | 959 | 1.940 |
Why?
| | Dendritic Cells | 8 | 2020 | 435 | 1.730 |
Why?
| | Flagellin | 6 | 2020 | 15 | 1.390 |
Why?
| | Berylliosis | 5 | 2022 | 177 | 1.340 |
Why?
| | Lung Injury | 2 | 2022 | 198 | 1.230 |
Why?
| | Adaptive Immunity | 7 | 2022 | 155 | 1.090 |
Why?
| | Sarcoidosis | 3 | 2022 | 135 | 1.020 |
Why?
| | Monocytes | 5 | 2021 | 504 | 0.910 |
Why?
| | Macrophages, Alveolar | 5 | 2020 | 348 | 0.880 |
Why?
| | HLA-DP beta-Chains | 3 | 2021 | 76 | 0.720 |
Why?
| | Salmonella Infections | 3 | 2020 | 50 | 0.700 |
Why?
| | Salmonella typhimurium | 4 | 2020 | 164 | 0.690 |
Why?
| | Lung | 8 | 2021 | 3561 | 0.680 |
Why?
| | Melanoma, Experimental | 1 | 2018 | 89 | 0.600 |
Why?
| | CD11b Antigen | 2 | 2018 | 57 | 0.570 |
Why?
| | Immunoglobulin M | 1 | 2018 | 246 | 0.570 |
Why?
| | Antigens, Neoplasm | 1 | 2018 | 222 | 0.560 |
Why?
| | Beryllium | 4 | 2022 | 146 | 0.550 |
Why?
| | Spermatozoa | 2 | 2008 | 84 | 0.550 |
Why?
| | Membrane Lipids | 2 | 2008 | 87 | 0.550 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2018 | 687 | 0.540 |
Why?
| | B-Lymphocytes | 2 | 2019 | 766 | 0.540 |
Why?
| | Liposomes | 2 | 2008 | 146 | 0.530 |
Why?
| | Mice, Knockout | 9 | 2020 | 2570 | 0.520 |
Why?
| | Mice | 22 | 2023 | 14869 | 0.520 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2016 | 39 | 0.520 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 343 | 0.500 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2015 | 41 | 0.490 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2014 | 17 | 0.480 |
Why?
| | Skin Transplantation | 1 | 2015 | 57 | 0.480 |
Why?
| | Salmonella typhi | 1 | 2014 | 11 | 0.460 |
Why?
| | Mice, Inbred C57BL | 14 | 2020 | 4694 | 0.450 |
Why?
| | Lymph Nodes | 4 | 2020 | 419 | 0.450 |
Why?
| | Animals | 28 | 2023 | 31706 | 0.440 |
Why?
| | Antigens, Bacterial | 1 | 2014 | 112 | 0.440 |
Why?
| | Integrin alpha Chains | 1 | 2013 | 22 | 0.430 |
Why?
| | Repressor Proteins | 2 | 2016 | 366 | 0.420 |
Why?
| | Toll-Like Receptor 5 | 4 | 2014 | 14 | 0.410 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 386 | 0.400 |
Why?
| | Graft Rejection | 1 | 2015 | 513 | 0.390 |
Why?
| | Granuloma | 3 | 2022 | 83 | 0.390 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2014 | 395 | 0.380 |
Why?
| | Antigens | 3 | 2021 | 318 | 0.370 |
Why?
| | Antigens, CD | 1 | 2013 | 442 | 0.360 |
Why?
| | Mice, Transgenic | 8 | 2021 | 1949 | 0.350 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 801 | 0.350 |
Why?
| | Phagocytes | 3 | 2020 | 90 | 0.330 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2021 | 127 | 0.330 |
Why?
| | Macrophages | 6 | 2021 | 1263 | 0.330 |
Why?
| | Signal Transduction | 4 | 2020 | 4513 | 0.310 |
Why?
| | Inflammation | 5 | 2022 | 2480 | 0.300 |
Why?
| | Myeloid Differentiation Factor 88 | 3 | 2019 | 90 | 0.290 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 206 | 0.280 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2021 | 170 | 0.270 |
Why?
| | Sperm-Ovum Interactions | 1 | 2006 | 12 | 0.260 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2177 | 0.260 |
Why?
| | Membrane Fusion | 1 | 2006 | 38 | 0.260 |
Why?
| | Oocytes | 1 | 2006 | 170 | 0.240 |
Why?
| | Spleen | 3 | 2016 | 487 | 0.230 |
Why?
| | Membrane Proteins | 3 | 2018 | 1019 | 0.230 |
Why?
| | Immunity, Innate | 4 | 2021 | 720 | 0.220 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1037 | 0.220 |
Why?
| | Cytokines | 5 | 2020 | 1841 | 0.210 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 146 | 0.200 |
Why?
| | Aspergillus nidulans | 1 | 2021 | 5 | 0.190 |
Why?
| | Antigen Presentation | 3 | 2014 | 188 | 0.190 |
Why?
| | Disease Models, Animal | 3 | 2022 | 3535 | 0.190 |
Why?
| | Chemokine CCL3 | 1 | 2021 | 15 | 0.190 |
Why?
| | Chemokine CCL4 | 1 | 2021 | 21 | 0.190 |
Why?
| | Group VI Phospholipases A2 | 1 | 2020 | 4 | 0.180 |
Why?
| | Cells, Cultured | 4 | 2020 | 3886 | 0.180 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2020 | 171 | 0.170 |
Why?
| | Interferon Type I | 1 | 2020 | 128 | 0.170 |
Why?
| | Gene Expression Regulation | 3 | 2020 | 2320 | 0.170 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2020 | 58 | 0.170 |
Why?
| | Tertiary Lymphoid Structures | 1 | 2019 | 6 | 0.170 |
Why?
| | Genome, Viral | 1 | 2020 | 118 | 0.170 |
Why?
| | Chemokine CXCL13 | 1 | 2019 | 7 | 0.170 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 206 | 0.160 |
Why?
| | Colitis | 1 | 2021 | 223 | 0.160 |
Why?
| | Intestinal Mucosa | 1 | 2023 | 532 | 0.160 |
Why?
| | Bacterial Proteins | 2 | 2014 | 736 | 0.160 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1518 | 0.160 |
Why?
| | CD40 Ligand | 1 | 2018 | 39 | 0.160 |
Why?
| | Antigen-Presenting Cells | 1 | 2018 | 150 | 0.150 |
Why?
| | Thermolysin | 1 | 2018 | 3 | 0.150 |
Why?
| | Chemokines | 1 | 2019 | 216 | 0.150 |
Why?
| | Collagenases | 1 | 2018 | 22 | 0.150 |
Why?
| | CD11c Antigen | 1 | 2018 | 38 | 0.150 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 66 | 0.150 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2018 | 43 | 0.150 |
Why?
| | T-Lymphocyte Subsets | 1 | 2020 | 383 | 0.150 |
Why?
| | Receptors, IgG | 1 | 2018 | 67 | 0.150 |
Why?
| | Flow Cytometry | 3 | 2016 | 1083 | 0.150 |
Why?
| | Inflammasomes | 2 | 2020 | 115 | 0.140 |
Why?
| | Lymphocytes | 1 | 2019 | 330 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 250 | 0.140 |
Why?
| | Bacterial Load | 2 | 2014 | 58 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 447 | 0.140 |
Why?
| | Cell Proliferation | 3 | 2014 | 2187 | 0.140 |
Why?
| | Ovalbumin | 3 | 2016 | 161 | 0.140 |
Why?
| | Mononuclear Phagocyte System | 1 | 2016 | 12 | 0.130 |
Why?
| | Antigens, Ly | 1 | 2016 | 45 | 0.130 |
Why?
| | Lung Diseases | 1 | 2022 | 701 | 0.130 |
Why?
| | Receptors, Immunologic | 2 | 2015 | 201 | 0.120 |
Why?
| | Histocompatibility Testing | 1 | 2015 | 116 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2020 | 1140 | 0.120 |
Why?
| | Syk Kinase | 1 | 2014 | 18 | 0.120 |
Why?
| | Chronic Disease | 4 | 2022 | 1578 | 0.120 |
Why?
| | Phagosomes | 1 | 2014 | 38 | 0.120 |
Why?
| | Receptors, Interleukin-2 | 1 | 2014 | 64 | 0.120 |
Why?
| | Adoptive Transfer | 1 | 2015 | 195 | 0.120 |
Why?
| | Germinal Center | 1 | 2014 | 48 | 0.120 |
Why?
| | Mice, Inbred BALB C | 2 | 2008 | 1144 | 0.120 |
Why?
| | Male | 10 | 2021 | 55596 | 0.120 |
Why?
| | Protease Inhibitors | 2 | 2005 | 97 | 0.120 |
Why?
| | Lysosomes | 1 | 2014 | 123 | 0.110 |
Why?
| | Transplantation, Homologous | 1 | 2015 | 377 | 0.110 |
Why?
| | Immunoglobulin G | 3 | 2021 | 770 | 0.110 |
Why?
| | Female | 10 | 2021 | 59507 | 0.110 |
Why?
| | Interleukin-2 | 1 | 2014 | 413 | 0.110 |
Why?
| | Th1 Cells | 1 | 2014 | 123 | 0.110 |
Why?
| | Cell Communication | 1 | 2014 | 280 | 0.110 |
Why?
| | Mesentery | 1 | 2013 | 53 | 0.110 |
Why?
| | Toll-Like Receptors | 1 | 2014 | 167 | 0.110 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1737 | 0.100 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2014 | 285 | 0.100 |
Why?
| | Gene Expression | 2 | 2014 | 1421 | 0.100 |
Why?
| | Salmonella Infections, Animal | 1 | 2011 | 36 | 0.090 |
Why?
| | Humans | 13 | 2022 | 114686 | 0.090 |
Why?
| | Endocytosis | 1 | 2010 | 148 | 0.080 |
Why?
| | Muramidase | 1 | 2010 | 72 | 0.080 |
Why?
| | Up-Regulation | 1 | 2012 | 808 | 0.080 |
Why?
| | Hypersensitivity, Delayed | 1 | 2008 | 27 | 0.080 |
Why?
| | Drug Compounding | 1 | 2008 | 89 | 0.080 |
Why?
| | CD4 Lymphocyte Count | 1 | 2008 | 257 | 0.070 |
Why?
| | Cell Line | 2 | 2020 | 2637 | 0.070 |
Why?
| | Drug Carriers | 1 | 2008 | 112 | 0.070 |
Why?
| | Immunophenotyping | 2 | 2020 | 274 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2008 | 1016 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 385 | 0.070 |
Why?
| | Cell Lineage | 2 | 2020 | 309 | 0.070 |
Why?
| | HIV Infections | 1 | 2020 | 2469 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 797 | 0.070 |
Why?
| | Transcription Factors | 1 | 2014 | 1528 | 0.070 |
Why?
| | Gene Targeting | 1 | 2006 | 75 | 0.060 |
Why?
| | Phaseolus | 1 | 2005 | 2 | 0.060 |
Why?
| | Amylases | 1 | 2005 | 13 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2008 | 719 | 0.060 |
Why?
| | Helminths | 1 | 2004 | 7 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2020 | 823 | 0.060 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 170 | 0.060 |
Why?
| | Insecta | 1 | 2004 | 64 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2086 | 0.060 |
Why?
| | Phagocytosis | 2 | 2016 | 350 | 0.060 |
Why?
| | Viruses | 1 | 2004 | 94 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2006 | 296 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 74 | 0.050 |
Why?
| | Plants | 1 | 2004 | 193 | 0.050 |
Why?
| | RNA | 2 | 2020 | 809 | 0.050 |
Why?
| | Toll-Like Receptor 4 | 2 | 2016 | 287 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 750 | 0.050 |
Why?
| | Interleukins | 1 | 2023 | 236 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 351 | 0.050 |
Why?
| | Heme | 1 | 2021 | 52 | 0.050 |
Why?
| | Heme Oxygenase-1 | 1 | 2021 | 52 | 0.050 |
Why?
| | Antigens, Fungal | 1 | 2021 | 24 | 0.050 |
Why?
| | HLA-DR3 Antigen | 1 | 2021 | 79 | 0.050 |
Why?
| | Hybridomas | 1 | 2021 | 230 | 0.050 |
Why?
| | Pyroptosis | 1 | 2020 | 2 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2021 | 119 | 0.050 |
Why?
| | Antigens, CD1 | 1 | 2020 | 57 | 0.040 |
Why?
| | Naphthalenes | 1 | 2020 | 38 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2020 | 45 | 0.040 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 5 | 0.040 |
Why?
| | Ketones | 1 | 2020 | 44 | 0.040 |
Why?
| | Lysophospholipids | 1 | 2020 | 65 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2020 | 149 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 573 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 129 | 0.040 |
Why?
| | Species Specificity | 1 | 2020 | 542 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2020 | 92 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 546 | 0.040 |
Why?
| | Adult | 4 | 2021 | 30550 | 0.040 |
Why?
| | Down-Regulation | 1 | 2020 | 594 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2020 | 590 | 0.040 |
Why?
| | Cell Membrane | 1 | 2020 | 680 | 0.030 |
Why?
| | Tryptophan | 2 | 2010 | 136 | 0.030 |
Why?
| | Organ Specificity | 1 | 2017 | 268 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 267 | 0.030 |
Why?
| | Thymocytes | 1 | 2016 | 28 | 0.030 |
Why?
| | Toll-Like Receptor 7 | 1 | 2016 | 35 | 0.030 |
Why?
| | Transplantation Chimera | 1 | 2015 | 51 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 870 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 338 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 330 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 304 | 0.030 |
Why?
| | Cadaver | 1 | 2016 | 299 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 78 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3003 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2014 | 157 | 0.030 |
Why?
| | Clone Cells | 1 | 2014 | 247 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 239 | 0.030 |
Why?
| | Chlamydia | 1 | 2014 | 10 | 0.030 |
Why?
| | CD4 Antigens | 1 | 2014 | 123 | 0.030 |
Why?
| | Salmonella | 1 | 2014 | 54 | 0.030 |
Why?
| | Smoking | 1 | 2020 | 1383 | 0.030 |
Why?
| | Ultraviolet Rays | 1 | 2016 | 363 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 740 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 313 | 0.030 |
Why?
| | Chlamydia muridarum | 1 | 2012 | 2 | 0.030 |
Why?
| | Mice, Congenic | 1 | 2012 | 21 | 0.030 |
Why?
| | Pulmonary Alveoli | 1 | 2015 | 373 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2014 | 219 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 75 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2015 | 477 | 0.030 |
Why?
| | Immunization | 1 | 2014 | 397 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1317 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 295 | 0.020 |
Why?
| | Chlamydia Infections | 1 | 2012 | 65 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2017 | 1313 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 26737 | 0.020 |
Why?
| | Genes, MHC Class II | 1 | 2010 | 69 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 725 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3408 | 0.020 |
Why?
| | Acrylamide | 1 | 2010 | 4 | 0.020 |
Why?
| | Potassium Chloride | 1 | 2010 | 32 | 0.020 |
Why?
| | Salts | 1 | 2010 | 36 | 0.020 |
Why?
| | Protein Denaturation | 1 | 2010 | 68 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2010 | 135 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 2796 | 0.020 |
Why?
| | Chickens | 1 | 2010 | 177 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 318 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 157 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2010 | 511 | 0.020 |
Why?
| | Protein Folding | 1 | 2010 | 239 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2363 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 805 | 0.020 |
Why?
| | Chromatography, DEAE-Cellulose | 1 | 2005 | 13 | 0.020 |
Why?
| | Cystine | 1 | 2005 | 14 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2005 | 73 | 0.020 |
Why?
| | Molecular Weight | 1 | 2005 | 331 | 0.020 |
Why?
| | Bacillus thuringiensis | 1 | 2004 | 4 | 0.020 |
Why?
| | Tyrosine | 1 | 2005 | 214 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 6115 | 0.010 |
Why?
| | Genetic Engineering | 1 | 2004 | 80 | 0.010 |
Why?
| | Genetic Markers | 1 | 2004 | 320 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 289 | 0.010 |
Why?
| | Kinetics | 1 | 2005 | 1551 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 2785 | 0.010 |
Why?
|
|
Atif's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|